DE60332915D1 - Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren - Google Patents

Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren

Info

Publication number
DE60332915D1
DE60332915D1 DE60332915T DE60332915T DE60332915D1 DE 60332915 D1 DE60332915 D1 DE 60332915D1 DE 60332915 T DE60332915 T DE 60332915T DE 60332915 T DE60332915 T DE 60332915T DE 60332915 D1 DE60332915 D1 DE 60332915D1
Authority
DE
Germany
Prior art keywords
alkoxy
acyl
amino
producing
nitrobenzoic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60332915T
Other languages
English (en)
Inventor
Scott Mason Duncan
Augustine Tobi Osuma
Sylvain Daigneault
Michel Bernatchez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Application granted granted Critical
Publication of DE60332915D1 publication Critical patent/DE60332915D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
DE60332915T 2002-02-05 2003-02-04 Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren Expired - Lifetime DE60332915D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35477702P 2002-02-05 2002-02-05
PCT/US2003/003437 WO2003066575A1 (en) 2002-02-05 2003-02-04 Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids

Publications (1)

Publication Number Publication Date
DE60332915D1 true DE60332915D1 (de) 2010-07-22

Family

ID=27734420

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60332915T Expired - Lifetime DE60332915D1 (de) 2002-02-05 2003-02-04 Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren

Country Status (11)

Country Link
US (2) US7227037B2 (de)
EP (1) EP1472213B1 (de)
JP (1) JP4361375B2 (de)
CN (2) CN101050189A (de)
AT (1) ATE470656T1 (de)
AU (1) AU2003217323A1 (de)
BR (1) BR0307375A (de)
CA (1) CA2475141A1 (de)
DE (1) DE60332915D1 (de)
MX (1) MXPA04007495A (de)
WO (1) WO2003066575A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003217323A1 (en) * 2002-02-05 2003-09-02 Wyeth Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids
US7109337B2 (en) 2002-12-20 2006-09-19 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
WO2004056807A1 (en) 2002-12-20 2004-07-08 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
JP2007537235A (ja) 2004-05-14 2007-12-20 ファイザー・プロダクツ・インク 異常細胞増殖の治療用ピリミジン誘導体
MXPA06013165A (es) 2004-05-14 2007-02-13 Pfizer Prod Inc Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal.
EP1751142A1 (de) 2004-05-14 2007-02-14 Pfizer Products Incorporated Pyrimidinderivate zur behandlung von anormalem zellwachstum
RU2007139544A (ru) * 2005-05-25 2009-06-27 Вайет (Us) Способ получения 3-цианохинолинов и промежуточные соединения, полученные согласно данному способу
WO2006127203A2 (en) * 2005-05-25 2006-11-30 Wyeth Methods of synthesizing 6-alkylaminoquinoline derivatives
RU2007143161A (ru) * 2005-05-25 2009-07-10 Вайет (Us) Способы синтеза замещенных 3-цианохинов и их продуктов
CA2816957A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
JP6358419B2 (ja) * 2013-12-27 2018-07-18 日産化学工業株式会社 脂環式テトラカルボン酸の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2138000A1 (en) * 1994-01-03 1995-07-04 John E. Starrett, Jr. Retinoid-like compounds
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
AU4545201A (en) * 2000-03-13 2001-09-24 American Cyanamid Co Method of treating or inhibiting colonic polyps
AU2003217323A1 (en) * 2002-02-05 2003-09-02 Wyeth Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids

Also Published As

Publication number Publication date
AU2003217323A1 (en) 2003-09-02
CN1330627C (zh) 2007-08-08
US20070219394A1 (en) 2007-09-20
JP2005517005A (ja) 2005-06-09
EP1472213B1 (de) 2010-06-09
CN101050189A (zh) 2007-10-10
US7294740B2 (en) 2007-11-13
US20050085662A1 (en) 2005-04-21
WO2003066575A1 (en) 2003-08-14
BR0307375A (pt) 2004-12-07
CN1628093A (zh) 2005-06-15
ATE470656T1 (de) 2010-06-15
US7227037B2 (en) 2007-06-05
CA2475141A1 (en) 2003-08-14
JP4361375B2 (ja) 2009-11-11
EP1472213A1 (de) 2004-11-03
MXPA04007495A (es) 2004-11-10

Similar Documents

Publication Publication Date Title
DE60328492D1 (de) Verfahren zur erzeugung von nanoteilchen
DE60330341D1 (de) Verfahren zur herstellung von wabenstrukturen
ATE408691T1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des mop-b
DE60210697D1 (de) Verfahren zur Produktion von L-Aminosäuren mittels Bakterien der Gattung Escherichia
DE60237184D1 (de) Verfahren zur Erzeugung von Bewegungen
DE60142831D1 (de) Verfahren zur herstellung von metall mit höherem reinheitsgrad
AT7109U3 (de) Verfahren zur herstellung von amlodipinmaleat
DE60125384D1 (de) Verfahren zur herstellung von gipsbauplatten mit erhöhter bruchfestigkeit
ATE395351T1 (de) Verfahren zur herstellung von thiocarboxylatsilan
ATE337270T1 (de) Verfahren zur herstellung von eisenoxiden
ATE452894T1 (de) Verfahren zur herstellung von salzen von 4-ää5- ä(cyclopropylamino)carbonylü-2- methylphenylüaminoü-5-methyl-n-propylpyrroloä2, - füä1,2,4ütriazin-6-carboxamid und damit hergestellte neue stabile formen
DE60332915D1 (de) Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren
DE60038560D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin
ATE316959T1 (de) Verfahren zur herstellung von 2- halogenpyridincarbonsäureamiden
DE502004001985D1 (de) Verfahren zur Herstellung von expandiertem Graphit
ATE301634T1 (de) Verfahren zur herstellung von alpha- hydroxycarbonsäureamiden
ATE274599T1 (de) Verfahren zur enzymatischen racematspaltung von aminomethyl-aryl-cyclohexanol-derivaten
DE60314113D1 (de) Verfahren zur herstellung von phenylorganosiliciumzwischenprodukten
ATE386027T1 (de) Verfahren zur herstellung von valsartan
DE50105715D1 (de) Verfahren zur herstellung von dnda
DE60318444D1 (de) Verfahren zur herstellung von nevirapin
ATE509899T1 (de) Verfahren zur rückgewinnung von cumol
ATE341558T1 (de) Verfahren zur herstellung von topiramate
DE50306461D1 (de) Verfahren zur herstellung von ph-sonden
DE50301977D1 (de) Verfahren zur Herstellung von gehärteten Bauteilen aus Stahl